Your browser doesn't support javascript.
loading
Comparison of the Cockcroft-Gault, MDRD and CKD-EPI equations for estimating ganciclovir clearance.
Palacio-Lacambra, Maria-Eugenia; Comas-Reixach, Immaculada; Blanco-Grau, Albert; Suñé-Negre, Josep-Maria; Segarra-Medrano, Alfonso; Montoro-Ronsano, José-Bruno.
Afiliación
  • Palacio-Lacambra ME; Department of Pharmacy, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Comas-Reixach I; Department of Biochemistry, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Blanco-Grau A; Department of Biochemistry, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Suñé-Negre JM; Pharmacy Faculty, University of Barcelona, Barcelona, Spain.
  • Segarra-Medrano A; Department of Nephrology, Arnau de Vilanova University Hospital, Lleida, Spain.
  • Montoro-Ronsano JB; Department of Pharmacy, Vall d'Hebron University Hospital, Barcelona, Spain.
Br J Clin Pharmacol ; 84(9): 2120-2128, 2018 09.
Article en En | MEDLINE | ID: mdl-29791023
AIMS: Accurately estimating kidney function is essential for the safe administration of renally cleared drugs such as ganciclovir. Current practice recommends adjusting renally eliminated drugs according to the Cockcroft-Gault equation. There are no data on the utility of the Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations in ganciclovir dosing. To evaluate which renal function equation best predicts ganciclovir clearance. METHODS: The performance of the Cockcroft-Gault equation, isotope dilution mass spectrometry (IDMS)-traceable 4-variable MDRD study (MDRD4-IDMS) equation and CKD-EPI equation in determining ganciclovir clearance were assessed retrospectively in patients treated with ganciclovir from 2004-2015. The MDRD4-IDMS and CKD-EPI equations adjusted to individual body surface area (MDRD4-IDMS·BSA and CKD-EPI·BSA, respectively) were also evaluated. Patients with intravenous ganciclovir peak and trough concentrations in their medical records were included in the study. Ganciclovir clearance was calculated from serum concentrations using a one-compartment model. The five equations were compared based on their predictive ability, the coefficient of determination, through a linear regression analysis. The results were validated in a group of patients. RESULTS: One hundred patients were included in the final analysis. Seventy-four patients were analysed in the learning group and 26 in the validation group. The coefficient of determination was 0.281 for Cockcroft-Gault, 0.301 for CKD-EPI·BSA, 0.308 for MDRD4-IDMS·BSA, 0.324 for MDRD4-IDMS and 0.360 for CKD-EPI. Subgroup analysis also showed that CKD-EPI is a better predictor of ganciclovir clearance. Analysis of the validation group confirmed these results. CONCLUSIONS: The CKD-EPI equation correlates better with ganciclovir clearance than the Cockcroft-Gault and MDRD4-IDMS equations, even the clinical difference between the equations is scarce.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Ganciclovir / Insuficiencia Renal Crónica / Eliminación Renal / Modelos Biológicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Ganciclovir / Insuficiencia Renal Crónica / Eliminación Renal / Modelos Biológicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: España
...